Skip Navigation



Hum. Reprod. Advance Access published online on March 8, 2007
Human Reproduction, doi:10.1093/humrep/dem037
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
22/6/1705    most recent
dem037v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Donoghue, J. F.
Right arrow Articles by Rogers, P. A.W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donoghue, J. F.
Right arrow Articles by Rogers, P. A.W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Lymphangiogensis of normal endometrium and endometrial adenocarcinoma

Jacqueline F. Donoghue1, Fiona L. Lederman1, Beatrice J. Susil2 and Peter A.W. Rogers1,3

1 Centre for Women's Health Research, Monash University Department of Obstetrics and Gynaecology, Clayton, Victoria, Australia 2 Department of Anatomical Pathology, Monash Medical Centre, Clayton, Victoria, Australia

3 To whom correspondence should be addressed at: Centre for Women's Health Research, Monash University Department of Obstetrics and Gynaecology, Monash Medical Centre, Level 5, 246 Clayton Road, Clayton, 3168 Victoria, Australia. E-mail: peter.rogers{at}med.monash.edu.au

BACKGROUND: Information about lymphatics and lymphangiogenesis in the human endometrium is limited. We investigated the distribution of endometrial lymphatic vessels during the normal menstrual cycle and in association with endometrial adenocarcinoma and investigated the expression of lymphangiogenic growth factors, vascular endothelial growth factor (VEGF)-C, VEGF-D and VEGF receptor-3 (VEGF-R3).

METHODS AND RESULTS: Full thickness uterine samples (n = 23 proliferative; n = 23 secretory) and endometrial adenocarcinoma samples (n = 7 grade I; n = 10 grade III) were collected for the study and analysed by immunohistochemistry and western blotting. Lymphatic vessels of the functionalis were significantly reduced compared with basalis (P = 0.001) across the menstrual cycle with lymphatics of the basalis sometimes intimately associated with spiral arterioles. Lymphatic vessels of endometrial adenocarinomas were located intra-tumoural and peri-tumoural with significant increases in the peri-tumoural lymphatic vessels compared with normal basalis (P = 0.02). Interestingly, high-grade adenocarcinoma vessels containing tumour emboli demonstrated a mixed blood/lymphatic endothelial cell phenotype. VEGF-C and VEGF-D were immunolocalized in glandular epithelium and some stromal cells with the staining intensity of this localization increasing in endometrial adenocarcinoma. Protein analysis identified VEGF-C (58, 41, 31 and 21 kD) and VEGF-D (56, 41, 31 and 21 kD) and VEGF-R3 (148 and 65 kD) peptides in normal endometrium, with significant increases in several of these peptides for VEGF-C and VEGF-D and no changes in protein expression for VEGF-R3 in endometrial adenocarcinoma.

CONCLUSION: Endometrial lymphatics are significantly reduced in the functionalis, and increases in endometrial adenocarcinoma peri-tumoural lymphatics are associated with increases in VEGF-C and VEGF-D peptides.

Key words: endometrial adenocarcinoma/endometrium/lymphangiogenesis/vascular endothelial growth factor C/vascular endothelial growth factor D


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ReproductionHome page
J. E Girling and P. A W Rogers
Regulation of endometrial vascular remodelling: role of the vascular endothelial growth factor family and the angiopoietin-TIE signalling system
Reproduction, December 1, 2009; 138(6): 883 - 893.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. C. Douglas, H. Tang, R. Gomez, B. Pytowski, D. J. Hicklin, C. M. Sauer, J. Kitajewski, M. V. Sauer, and R. C. Zimmermann
Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Functions to Promote Uterine Decidual Angiogenesis during Early Pregnancy in the Mouse
Endocrinology, August 1, 2009; 150(8): 3845 - 3854.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
P. A. W. Rogers, J. F. Donoghue, L. M. Walter, and J. E. Girling
Endometrial Angiogenesis, Vascular Maturation, and Lymphangiogenesis
Reproductive Sciences, February 1, 2009; 16(2): 147 - 151.
[Abstract] [PDF]

Home page
 Hum ReprodHome page
S. Quenby, H. Nik, B. Innes, G. Lash, M. Turner, J. Drury, and J. Bulmer
Uterine natural killer cells and angiogenesis in recurrent reproductive failure
Hum. Reprod., January 1, 2009; 24(1): 45 - 54.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. Zhang, H. Dong, B. Wang, S. Zhu, and B. A. Croy
Dynamic Changes Occur in Patterns of Endometrial EFNB2/EPHB4 Expression During the Period of Spiral Arterial Modification in Mice
Biol Reprod, September 1, 2008; 79(3): 450 - 458.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.